After failure. Put MSBU out if its misery already. Nobody here could sell their way out of a paper bag
Nobody is happy in MSBU. Not one person. Are you listening senior leaders??? At some point it's time to cut your losses and throw in the towel. Gilenya has failed not because it's a bad product. It's Actually very good. It's because of MSBU leadership. You can hammer metrics, SOV, reach and freq till you are blue in the face. That does not work in Neurology and has actually a negative effect on market share. Proof of this is Tecfidera. They are kicking our asses yet they don't worry about metrics. It's unfortunately too late. KOLs don't respect us and this SAM experiment has failed miserably. The latest trebds show it. Just throw in the towel. It's over, o-v-er
You need to adjust your expectations down. The product will never be market leader, never be competitive, simply make $. Possibly billions over product lifespan so , why not sell it? Many companies would love to have a product that makes as much $. Then there is also the possibility of other neuro products to follow, or other indications for this one.
